Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing Roongruedee Chaiteerakij,

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

The GAPs between hepatocellular carcinoma and RAS

Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR Nicolas Marsollier, Pascal Ferré,

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Reactive oxygen species in the normal and acutely injured liver

Cédric Coulouarn, Bruno Clément Journal of Hepatology

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Volume 69, Issue 2, Pages (August 2018)

The place of downstaging for hepatocellular carcinoma

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Volume 68, Issue 3, Pages (March 2018)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Why men are at higher risk for hepatocellular carcinoma?

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Autophagy in the liver Journal of Hepatology

Who should get a liver graft?

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 50, Issue 4, Pages (April 2009)

Cédric Coulouarn, Bruno Clément Journal of Hepatology

Portal vein thrombosis, cirrhosis, and liver transplantation

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

Evolution of liver transplantation for hepatocellular carcinoma

Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Volume 42, Issue 6, Pages (June 2005)

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

The use of hemospray in portal hypertensive bleeding; a case series

Epigenetic modifications as new targets for liver disease therapies

Chronic hepatitis B in children and adolescents

Volume 62, Issue 3, Pages (March 2015)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

New trials and results in systemic treatment of HCC

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Table of contents The Journal for Nurse Practitioners

Donor-recipient matching: Myths and realities

Chimeric mouse model of hepatitis B virus infection

Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98] Angela Douglass,

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

Genetics of hepatocellular carcinoma: The next generation

Volume 64, Issue 6, Pages (June 2016)

The dawn of a new EASL – A new chapter in the history of the European Association for the Study of the liver Tom H. Karlsen, Phil N. Newsome Journal.

Presentation transcript:

Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing Roongruedee Chaiteerakij, Lewis R. Roberts Journal of Hepatology Volume 58, Issue 5, Pages 1042-1044 (May 2013) DOI: 10.1016/j.jhep.2012.11.046 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Study design, methods, and key findings from next generation sequencing analyses of HBV-related HCCs. ∗RNAi screening is a method to study loss of function of genes by targeting the gene mRNAs using inhibitory RNAs that accelerate mRNA degradation. Journal of Hepatology 2013 58, 1042-1044DOI: (10.1016/j.jhep.2012.11.046) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions